DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/45vkmt/european_sleep) has announced the addition of the "European Sleep Apnea Devices Market, by Segment (Sleep Apnea Diagnostic Devices (Home Sleep Testing, Respiratory Polygraphs, Actigraphy Systems) and Sleep Apnea Therapeutic Devices (Pap Devices, Oxygen Devices, Airway Clearance Systems)-Forecast to 2019" report to their offering.
The European sleep apnea devices market is projected to grow at a CAGR of 16.0% from 2014 to 2019
Germany holds the largest share of the European sleep apnea devices market. This large share of the German segment is attributed to the various driving forces, such as the increasing prevalence of sleep disorders in this region, increasing awareness level among patients and caregivers, rising number of cases of cardiovascular disorders, and the availability of technologically advanced diagnostic and therapeutic devices. However, the inadequate reimbursement coverage and patient compliance are perceived to hinder the growth of this market in the coming years. The high costs associated with the diagnosis and treatment of sleep apnea also restrains the growth of devices market in this region.
The research report classifies the European sleep apnea devices market on the basis of segment into sleep apnea therapeutic devices and sleep apnea diagnostic devices. The sleep apnea therapeutic devices is further segmented based on types into home sleep testing/portable monitoring, sleep labs, respiratory polygraphs, two channel screening devices, single channel screening devices, and actigraphy systems. Similarly, the sleep apnea therapeutic devices market is segmented based on the types into Positive Airway Pressure (PAP) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances. The PAP devices segment is the largest contributor in the therapeutic devices market. Moreover, the therapeutic devices segment is the largest contributor to the overall European sleep apnea devices market, having accounted for a share of 58.1% in 2014.
Further, the European sleep apnea devices market is segmented based on the major countries of the region, such as Germany, France, the U.K., Italy, Spain, and the Rest of Europe (RoE). Germany is the largest market for sleep apnea devices in Europe. It accounted for a share of 27.9% of the European sleep apnea devices market in 2014. The major factors contributing to its dominance are the increasing prevalence of sleep disorders, rising awareness among patients and caregivers, and availability of advanced diagnosis and therapy options. France is the second-largest market in Europe and is projected to grow at a CAGR of 16.6% from 2014 to 2019. The U.K. houses the fastest-growing segment of the European sleep apnea devices market, and is projected to grow at the fastest CAGR from 2014 to 2019. The rising research & development activities pertaining to sleep disorders, rising obesity rates, and increasing awareness levels among patients and caregivers, are some of the factors expected to drive the growth of the European sleep apnea devices market in the coming years.
Companies Mentioned
- Ambulatory Monitoring, Inc.
- BMC Medical Co., Ltd.
- Carefusion Corporation
- Compumedics Limited
- Devilbiss Healthcare
- Fisher and Paykel Healthcare Ltd.
- Itamar Medical, Ltd.
- Natus Medical, Inc.
- Nihon Kohden
- Nonin Medical
- Philips Respironics (Subsidiary of Philips Healthcare Ltd.)
- Resmed, Inc.
- Somnomedics Gmbh
- Weinmann Medical Devices Gmbh & Co. Kg
For more information visit http://www.researchandmarkets.com/research/45vkmt/european_sleep
